3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Phase 2
1
Status
Active not recruiting
5
Unknown
2
Recruiting
2
Completed
2
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
28
Carcinoma, Non-Small-Cell Lung
23
Lung Neoplasms
17
Biliary Tract Neoplasms
13
Small Cell Lung Carcinoma
12
Cholangiocarcinoma
12
Triple Negative Breast Neoplasms
8
Breast Neoplasms
8
Neoplasms
6
Neoplasm Metastasis
5
Liver Neoplasms
5
Urinary Bladder Neoplasms
4
Stomach Neoplasms
4
Carcinoma
4
Pancreatic Neoplasms
3
Non-Muscle Invasive Bladder Neoplasms
3
Gallbladder Neoplasms
3
Colorectal Neoplasms
3
Adenocarcinoma Of Esophagus
3
Pathologic Complete Response
2
Ovarian Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Bile Duct Neoplasms
2
Advanced Biliary Tract Cancer
2
Adenocarcinoma of Lung
2
Adenocarcinoma
2
Vaccinia
1
SCLC, Limited Stage
1
Resectable Intrahepatic Cholangiocarcinoma
1
Interventions
pembrolizumab
25
Paclitaxel
20
Carboplatin
17
Bevacizumab
12
Specimen Handling
10
Letrozole
10
abemaciclib
7
dostarlimab
6
Taxes
6
Blood Specimen Collection
6
Medroxyprogesterone Acetate
5
Magnetic Resonance Spectroscopy
5
Fulvestrant
5
Drug Therapy
5
Doxorubicin
5
Cisplatin
5
Biopsy
5
olaparib
4
lenvatinib
4
atezolizumab
4
Radiotherapy
4
Progestins
4
Observation
4
Nivolumab
4
Megestrol Acetate
4
Immunoglobulin G
4
Gemcitabine
4
trastuzumab deruxtecan
3
palbociclib
3
X-Rays
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Endometrial Neoplasms
×
durvalumab
×
Clear all
NCT06680739
2026-06-01
SERPENTINE
Vall d'Hebron Institute of Oncology
Phase 2
Recruiting
60 enrolled
NCT05255653
2026-05-15
RAINBO
Leiden University Medical Center
Phase 2/3
Recruiting
1,615 enrolled